Table 3.

Adverse Events, by Intervention Group

	Yoga Group N=28	Control Group N=28	P-valuea
Total number of adverse eventsb reported	23	25	0.77
Number of participants with at least one adverse eventb	17	14	0.59
Total number of adverse events by body/organ system
Gastrointestinal adverse events	0	2	0.16
Genitourinary adverse events	1	0	0.32
Musculoskeletal adverse events	9	8	0.80
Neurological or psychological adverse events	4	4	1.00
Ophthalmologic adverse events	1	3	0.32
Respiratory or sinus adverse events	8	9	0.80
Number of participants with an adverse event by body system
Gastrointestinal adverse events	0	2	0.16
Genitourinary adverse events	1	0	0.32
Musculoskeletal adverse events	8	7	0.80
Neurological or psychological adverse events	4	4	1.00
Ophthalmologic adverse events	1	3	0.32
Respiratory or sinus adverse events	8	9	0.80
Total number of serious adverse eventsc	0	0	1.00
Number of participants with serious adverse eventsc	0	0	1.00

^aP-values for between-group differences in adverse events were calculated from chi-square goodness-of-fit tests.

^bAdverse events were assessed at each study visit or phone call by asking participants to report any negative changes in health since their last visit or call, regardless of relationship to study participation.

^cSerious adverse events were defined by the standard definition of death, life-threatening event, hospitalization, or permanent disability